Ardent Health (NYSE:ARDT – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.780-1.150 for the period, compared to the consensus EPS estimate of 1.220. The company issued revenue guidance of $6.4 billion-$6.7 billion, compared to the consensus revenue estimate of $6.5 billion.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on ARDT. Royal Bank Of Canada reduced their price objective on shares of Ardent Health from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, July 9th. Wall Street Zen downgraded shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Truist Financial cut their target price on shares of Ardent Health from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Tuesday, July 14th. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Finally, UBS Group lifted their price target on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $14.04.
View Our Latest Report on ARDT
Ardent Health Trading Down 0.1%
Ardent Health (NYSE:ARDT – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, analysts expect that Ardent Health will post 1.06 EPS for the current year.
Insider Buying and Selling
In other news, CFO Alfred Lumsdaine bought 10,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the acquisition, the chief financial officer directly owned 329,183 shares in the company, valued at $2,900,102.23. This represents a 3.13% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.90% of the company’s stock.
Institutional Investors Weigh In On Ardent Health
A number of large investors have recently made changes to their positions in ARDT. Geode Capital Management LLC boosted its position in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after acquiring an additional 1,769 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of Ardent Health by 8.3% in the second quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company’s stock worth $376,000 after purchasing an additional 2,110 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its position in shares of Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after purchasing an additional 2,638 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Ardent Health by 24.8% during the third quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock worth $218,000 after purchasing an additional 3,272 shares during the period. Finally, New York State Common Retirement Fund boosted its holdings in shares of Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after purchasing an additional 3,400 shares during the period.
About Ardent Health
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Featured Stories
- Five stocks we like better than Ardent Health
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
